COVID-19 Updates: Get the latest information from our experts: Vaccines Testing Visitor Guidelines Closings

Infectious Disease

infectious diseases image

Tirelessly Protecting Against Infectious Diseases

Rochester Regional Health Infectious Disease provides clinical and consulting services regarding the diagnosis and treatment of acute and chronic infectious diseases. The unit also provides expertise and leadership in epidemiology and infection control programs.

The unit consists of four physicians who are board-certified in both Internal Medicine and Infectious Disease and are full-time faculty of the University of Rochester.

Consulting Services

  • Provide direction and guidance for the infection control program at Rochester Regional Health

  • In-hospital and outpatient consultation with attending physicians

  • In-home antibiotic delivery for patients on home-care

  • Consultation with nursing homes and home-care programs within the health system

  • HIV/AIDS, Hepatitis C testing and treatment services

The New York State screening guidelines for hepatitis C help to identify patients who may be infected with hepatitis C but unaware of their status. Our providers evaluate and treat a wide spectrum of infectious diseases including but not limited to hepatitis C and HIV/AIDS. Patients will meet with one of our experiences providers for a comprehensive evaluation and to establish a treatment plan.

Infectious Disease Services

  • Confidential testing for hepatitis C, HIV, and other sexually transmitted illnesses
  • Pre-exposure Prophylaxis (PrEP) Evaluations
  • Outpatient IV treatment management
  • General infectious disease management
  • Intensive case management
  • Social work intervention
  • Bilingual staff and interpreting
  • TTY services
  • Financial assistance
  • Education and counseling

Research

Rochester Regional Health is involved in the research of respiratory viruses. NIH-sponsored research programs in the epidemiology, immunology, and clinical impact of respiratory viruses including Respiratory Syncytial Virus, Influenza virus, and human Metapneumoviruses, with an emphasis on elderly and high-risk persons. Additional research involves the development of newer molecular diagnostic tests for respiratory viruses, and the development, and testing of potential new vaccines for these viruses.

Our Featured Experts